In bladder cancer, lentinan is an isolated botanical drug metabolite that induces macrophage activation in a bladder cancer mouse model, promoting the proliferation of CD4+ and CD8+ T cells while upregulating the expression of IFN-γ and IL-2. This evidence concerns the gene IL2 and urinary bladder carcinoma.